EUVIMEDEUVIMED entdecken
Open Access

Localized immunomodulation with cytokine-producing cells to mitigate foreign body responses in rodents and a nonhuman primate

Boram Kim iD, Dilrasbonu Vohidova iD, Amanda Nash iD, Yuen San Chan iD, Samantha Fleury iD, Shravani Deo, Danna Murungi, Peter D Rios iD, Ira Joshi iD, Hafsa Nasir iD, Daisy Lopez iD, Mor Sela Golan iD und 4 weitere

Science Advances · 2026

DOI: 10.1126/sciadv.aec7053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Boram Kim und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Rice University, Houston, TX, USA. Hauptthemen laut MEDLINE: Immunomodulation, Foreign-Body Reaction, Cytokines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Advanced Research Projects Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The efficacy of cell-based therapeutics is often compromised by host immune recognition of implanted cells and biomaterials, resulting in fibrotic encapsulation and loss of function. Here, we address this challenge with an immunomodulatory cell-based therapy, in which alginate-encapsulated retinal pigment epithelial cells continuously secrete cytokines to locally modulate the implant microenvironment. In a healthy rodent model, the localized production of interleukin-10 (IL-10) or IL-12 from encapsulated cytokine-producing cells prevented foreign body response to alginate capsules. Mechanistically, treatment was associated with reduced expression of profibrotic genes and immune shifts consistent with macrophage and T cell regulation, supporting a cytokine-mediated mitigation of foreign body response. In a diabetic murine model (streptozotocin-induced C57BL/6J), coimplantation of human islets with IL-10–producing cells attenuated pericapsular fibrosis, preserved islet viability, and restored normoglycemia for up to 100 days (4.76 times longer than islets alone). Notably, IL-10–producing cells were also effective in enabling the durability and function of encapsulated cells in a healthy nonhuman primate, showing translational feasibility. Collectively, these findings suggest that localized cytokine delivery can reduce fibrotic encapsulation and support durable graft function, offering a path to lessen reliance on systemic immunosuppression in islets transplantation and other implantable biomaterial therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunomodulationForeign-Body ReactionCytokinesAnimalsInterleukin-10HumansMiceDiabetes Mellitus, ExperimentalIslets of Langerhans TransplantationMaleIslets of LangerhansInterleukin-12

Substanzen

Interleukin-10CytokinesInterleukin-12

Autor:innen und Institutionen

  • Department of Bioengineering, Rice University, Houston, TX, USA.
  • Department of Molecular and Cellular Biology and Center for Precision Environmental Health, Baylor College of Medicine, Houston, TX, USA.
  • CellTrans Inc., Chicago, IL, USA.
  • Department of Visceral and Transplant Surgery, University of Zurich, University Hospital Zurich, Zurich, Switzerland.
  • Rice Biotechnology Launch Pad, Rice University, Houston, TX, USA.

ORCID-Profile: Boram Kim, Dilrasbonu Vohidova, Amanda Nash, Yuen San Chan, Samantha Fleury, Peter D Rios, Ira Joshi, Hafsa Nasir, Daisy Lopez, Mor Sela Golan, Jose Oberholzer, H Courtney Hodges, Omid Veiseh

Förderung

  • NCI NIH HHS
  • Advanced Research Projects Agency

Zitieren

APA

Kim, B., Vohidova, D., Nash, A., Chan, Y. S., Fleury, S., Deo, S., Murungi, D., Rios, P. D., Joshi, I., Nasir, H., Lopez, D., Golan, M. S., Hart, C., Oberholzer, J., Hodges, H. C., & Veiseh, O. (2026). Localized immunomodulation with cytokine-producing cells to mitigate foreign body responses in rodents and a nonhuman primate. Science Advances. https://doi.org/10.1126/sciadv.aec7053

Vancouver

Kim B, Vohidova D, Nash A, Chan YS, Fleury S, Deo S, et al. Localized immunomodulation with cytokine-producing cells to mitigate foreign body responses in rodents and a nonhuman primate. Science Advances. 2026. doi:10.1126/sciadv.aec7053

BibTeX
@article{Kim2026,
  author = {Kim, Boram and Vohidova, Dilrasbonu and Nash, Amanda and Chan, Yuen San and Fleury, Samantha and Deo, Shravani and Murungi, Danna and Rios, Peter D and Joshi, Ira and Nasir, Hafsa and Lopez, Daisy and Golan, Mor Sela and Hart, Cassidy and Oberholzer, Jose and Hodges, H Courtney and Veiseh, Omid},
  title = {Localized immunomodulation with cytokine-producing cells to mitigate foreign body responses in rodents and a nonhuman primate},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aec7053}
}
Kostenlos starten →